ertu Medical Technologies Group

The Collaborative Endeavor Opportunities (CEO) Division that produces, markets products and oversees businesses generated from PIN

The Plexus Healthcare Technology Development Network or Plexus Innovation Network (PIN)

The Aegis Medical Technology Fund that can support C.E.O. projects and outside businesses with venture capital eventually providing a return to investors.

A Holding Company with 3 Core Divisions

The Problems

Innovation Processes are Top Down instead of Bottom Up

Frontline healthcare providers are not incentivizedto create technical innovations with profit sharing or royalties and are financially constrained without access to corporate R & D budgets.

Medical technology Development cycles are too long, resulting in less innovation.

As one example, the current IP development, processing and approval process is backlogged by over 750,000 U.S. patents pending

IP & Funding Restrictions for Frontline Healthcare providers.

Medical IP & Funding is owned and controlled by a select group of corporations instead of shared.

Global IP filing is prohibitively expensive and complex.

Patent infringement cases crossing borders also present legal framework challenges and patent law disparities that make global IP protection difficult to achieve or enforce.

The Solutions

Incentive Innovators

Distribute the ownership of

healthcare IP to its frontline

providers using the IP

blockchain

Create a Fund

Create a medical technology

investment resource that will

help fund the innovation

provider network

Simplify Patents

Help resolve the patent

process backlog by applying

tokens that replace the

concept of patent filings with

blockchain titles

Create a global healthcare

innovation provider network

that share the load to get to

market faster with improved

products

IP Tracking

Develop an IP tracking

system for use from concept

to completion with a utility

token.

Share the Success

Develop a platform for

distributing IP royalty

payments throughout the

development network.

Reduce the Cost & Time

Vertu Is Already Conceiving 10 Innovations

~$250m / Per Innovation

Estimate Per Innovation Value

If calculated at a conservative 5%

>$7 Trillion

Industry Value

Expected to grow >$10 Trillion by 2022

$2.5 Billion

Value of Innovations

Yearly Revenue

25%

Growth

MARKET PROJECTION

Market value expected to

increase 5% Annually,

increasing over

$3 Trillion by 2022

$10

$15

$20

2016 2018 2020 2022 2024

Surgical Equipment Market Forecast

Market

Value($ bln)

Reference: Grand View Research Inc, July, 2017 <https://www.grandviewresearch.com/press-release/global-surgical-equipment-market>

Market Research

SolutionsJohnson & Johnson Medtronics

Funding Support for Innovators

Creating Innovative Products

Accessible Product to Market Route

Innovator’s Patent Recognition &

Royalties

Patent Filing Platform

Accessible Innovation Provider

Network

Bayer

+$340 Billion +$50 Billion +$39 Billion

Competitors Comparison

VERTU MEDICAL TECHNOLOGIES

GROUP OF COMPANIES

AEGIS FUNDPLEXUS DEVELOPMENT

NETWORKCEO NETWORK

PLEXUS IPBLOCKCHAIN SaaS

STO, IEO, PLEXUS

PROJECTS &

BUSINESSES FUND

ROYALTY INCOME

GENERATES,

COORDINATES &

RECORDS

INNOVATIONS

FEEDS CEO SUPPORTS PLEXUS

DEVELOPS

INNOVATIONS &

BUSINESSES

INCOME SOURCE

FROM PDN AS SaaS

FEEDS ROYALTY

SYSTEM & AEGIS W/

ROYALTY

INNOVATIONS

TRACKS ALL PDN

ACTIVITIES, USES PLX

TOKEN

OFFERS

MANAGEMENT

TRACKS, USES PLX

TOKEN

DISTRIBUTE

DIVIDENDS, USES

AFT TOKENS

The Ecosystem

What We’ve AchievedLegal Business Entities Established

2018

Vertu Realities

2019

Innovations Progressed

Office & Facility construction.

Domains purchased

10 of the 90 innovations progressing. One of the

innovations almost ready for market.

Self Funded

Spend Thus Far: $1,000,000 USD

Innovation Ready for Scaling

$100m+ Potential

Q4 2019

Phase 1

Q2 2020

Phase 2

Fund Raise: $1 mil

Activity: Form core management team for Plexus, CEO, and Aegis Fund divisions

Begin Plexus IP blockchain development

Move most promising innovations through approval to royalty agreements.

Establish Aegis Fund board, CIO, criteria, and disbursement fund accounts.

Fund Raise: $3-5 mil

Activity: Plexus IP blockchain alpha phase testnet

Complete testing for one innovation & introduce to market

Initiate Aegis Fund investments for PI Network, businesses, and CEO activities

Begin offering CEO services to Plexus network partners and external companies

Progress can be achieved and scaling undertaken with either

the completion and progress to market of the Innovation, or

the undertaking of a public sale.

IEO or Innovation

Q2 2020

Phase 2

Fund Raise: $5-15 mil

Activity: Complete Plexus testnet and mainnet.

Complete beta protocol.

Set roll-out date for market introduction as a U.S. centric IP blockchain.

One innovation achieves market introduction and begins generating royalty payments for the

Aegis Fund. Other innovations move to prototype stages.

Roadmap

Incredible Growth

Timeline End

2021

Aegis funds innovations, produces dividends from previous medically oriented investments, funds

more innovations, seeds medical start-ups, begins paying dividends to AFT holders.

The CEO services division provides conceptual to production manufacturing and management

support for innovations now with linked suppliers and in-house assembly, testing, and marketing

functions.

This is based on a realistic raise structure. Getting

lower or higher amounts will affect the speed of this

progression.

Revenue will scale rapidly from the indicative $7M as

the innovations are released and further innovators

join.

Roadmap Timeline

Total: 6 Years

Revenue: $26M USD p.a

For 10 innovations

Total Raise: $15M-100M USD

2022

Activity: Plexus IP blocknet branches to global access in the key major languages of innovation

centers (China, U.S., Japan, South Korea, Eurozone, Germany, Russia, India, Canada, Brazil).

Multiple Plexus innovations reach market introduction, producing a growing stream of royalty

income of an estimated $XX million per year.

The Aegis Fund continues paying dividends, supporting Plexus network innovations, venture

funding medical start-ups, and appreciating assets under management to return an increasing

dividend to AFT holders.

The CEO services division expands in-house manufacturing capability, logistics, and management

as the Plexus network continues feeding innovations through the CEO business building process.

CEO services will be cash flow positive.

Revenue

COGS

Operating

NET INCOME

0.12

0.365

0.52

-0.76

4.47

2.424

1.08

0.95

7.5

3.862

1.06

2.6

Source 2020 2022 20242020

2021

2022

2023

2024

-636%

-14%

+21%

+32%

+34%

Financial Projection

Percentage Profit of Total Revenue

This projects only a single Innovation’s performance and return.

Vertu Realities directly has over 90 innovations prepared, 10 of which are presented in the White Paper.

Using this innovation as a stepping stone, Vertu Realities will see Exponential Growth

(Millions USD) (Millions USD) (Millions USD)

Fundraising Plans

Private Sale

Based on Fundraising amount, two paths can be undertaken. A further

public sale via IEO, or a product innovation launch

IEO 1.0

Reliant on market condition, should the private sale not prove to be as

fruitful, a public raise will then be undertaken.

Product Launch

One of the innovations will be brought to Market. The innovation’s

projected revenues will allow the company to grow sustainably without

further funding.

Series A

Larger sum of funding will be sought to scale the model aggressively

once the proof of concept has been established.

1

2

3

4

26%

3%

7%

11%14%

18%

21%

Dividends

Expenses

Fund

MarketingDevelopment

Product Building

Operating Expenses

Pre-Seed Target

Funds Distribution

$1,680,000 USD

Aegis Fund Tokenomics

Classification: Security TokenFull Name: Aegis Fund TokenToken Code: AFTInitial issuance: 1,009,003,247Protocol: ETH or EOS standardNetwork: Public, distributed qualified investors, developers, and Aegis FundConfirmation: PoS or DPoSSpeed: > 25 tpsConfirmation time: <10 secondsDevelopment language: Solidity or C++Limit of Issuance: 1,459,003,247Original Value: $0.10 early access.Servers Required: None. Runs on public, decentralized network.

Token distribution:

Initial sale – 15%: 151,350,487 AFTBonuses – 10%: 100,900,325 AFT

Retained by Aegis Team – 12% (6-24-month lock-up period): 121,080,390 AFT

Retained for Funding Allocation – 63%: 635,672,046 AFTD.

Dr. Richard A. Foster, MD

Co-Owner Vertu Realities LLC, Board member American Society of Chief Executive

Officers

35 year experience Emergency Medicine &

Trauma Physician

Parish Coroner reelected 18 years

Entrepreneur & Innovator

CEO & Founder IntelecomTechnologies

Board of Directors Japan Karate Association American Federation, 6th Degree Black

Belt, current US Karate National & Olympic Team

Coach

Extensive experience in motivational leadership,

computer and telecommunication

Dr. Dennis J. Morris, MD

CEO & Founder: Vertu Realities LLC, Vertu Medical

Technologies, American Society of Chief Executive Officers

35 year experience Emergency Medicine & Trauma Physician

Entrepreneur & Innovator with extensive I.P. portfolio

Extensive executive leadership experience

Chief Financial Officer & Board of Directors: Vertu

Realities LLC, Vertu Medical Technologies, American

Association of Chief Executive Officers

Escrow & Custodial Advisory

Director of National Project Management Division

Entrepreneur & Innovator

The Team

International Blockchain Consulting

Leaders in the Blockchain industry for expertise in

marketing, capital raising, technical development and business advice.

Mark Solomon

Career in engineering and R&D, transitioned to a

licensed financial adviser, commodities trader, online marketing consultant, and author of multiple financial books including one of the early books about Bitcoin.

Associates & Advisors

ertu Medical Technologies Group

contact@vertumedicaltechnologies.com

@vertumedicaltechnologies

www.vertumedicaltechnologies.com